Matthew Angel
CIK: 0001931356
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TPST
Tempest Therapeutics, Inc.
DirectorOfficer10% Owner
Discretionary Trading P&L
Holdings
About Angel Matthew
Angel Matthew (SEC CIK 0001931356) files insider reports with the SEC as CEO and President of Tempest Therapeutics, Inc. (TPST).
Signal8 holds 4 ownership filings by Angel Matthew (1 Form 3, 3 Form 4), filed between Feb 6, 2026 and Jun 23, 2026. Those filings report 2 transactions, from Feb 4, 2026 to Mar 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Angel Matthew's filings is in BRISBANE, CA.
Recent filings by Angel Matthew
Other insiders filing for Tempest Therapeutics, Inc. (TPST)
- Frederick John W., Director
- Smith Nancy Freda, Director
- Yee John D., Director
- Richey William Drake, Director
- Trojanowski Justin, Corporate Controller
- Maestas Nicholas, Chief Financial Officer